Literature DB >> 34415508

MR imaging findings of musculoskeletal involvement in microscopic polyangiitis: a comparison with inflammatory myopathy.

Masaya Kawaguchi1, Hiroki Kato2, Tomoaki Nagasawa2, Yo Kaneko2, Koichiro Taguchi3, Takahide Ikeda3, Hiroyuki Morita3, Tatsuhiko Miyazaki4, Masayuki Matsuo2.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the importance of MR imaging findings of musculoskeletal involvement of the lower limbs in diagnosing microscopic polyangiitis (MPA) vs polymyositis (PM) or dermatomyositis (DM).
MATERIALS AND METHODS: This study included 13 patients diagnosed with MPA clinically and through histologically, and 38 diagnosed with PM/DM, who underwent MR imaging of the lower limbs prior to treatment. Axial and coronal short tau inversion recovery (STIR) images were reviewed retrospectively.
RESULTS: The sites affected by MPA were the lower legs in six (46%) patients and the thighs in seven (54%). Intramuscular hyperintensity and fascial hyperintensity were observed in all cases of MPA (100%). Fascial hyperintensity was more frequently encountered in MPA than in PM/DM (100% vs. 45%, p < 0.01). As the predominantly involved sites, the fascial regions were more frequently affected by MPA than by PM/DM (77% vs. 18%, p < 0.01). Diffuse subcutaneous fat hyperintensity was more frequently observed in MPA than in PM/DM (100% vs. 16%, p < 0.01). However, no significant differences in intramuscular hyperintensity (100% vs. 97%, p = 0.745) and subcutaneous fat hyperintensity (54% vs. 50%, p = 0.533) were found between MPA and PM/DM.
CONCLUSION: Intramuscular hyperintensity and fascial hyperintensity have always been observed in MPA, and the predominantly affected sites were usually the fascial regions. Compared with PM/DM, fascial hyperintensity and diffuse subcutaneous fat hyperintensity were more frequent in MPA.
© 2021. Italian Society of Medical Radiology.

Entities:  

Keywords:  Inflammatory myopathy; MRI; Microscopic polyangiitis; Musculoskeletal abnormalities; STIR

Mesh:

Year:  2021        PMID: 34415508     DOI: 10.1007/s11547-021-01407-y

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  21 in total

1.  Microscopic polyangiitis presenting as a "pulmonary-muscle" syndrome: is subclinical alveolar hemorrhage the mechanism of pulmonary fibrosis?

Authors:  Julius Birnbaum; Sonye Danoff; Frederic B Askin; John H Stone
Journal:  Arthritis Rheum       Date:  2007-06

Review 2.  Microscopic polyangiitis: Advances in diagnostic and therapeutic approaches.

Authors:  Antonio Greco; Armando De Virgilio; Maria Ida Rizzo; Andrea Gallo; Giuseppe Magliulo; Massimo Fusconi; Giovanni Ruoppolo; Mario Tombolini; Rosaria Turchetta; Marco de Vincentiis
Journal:  Autoimmun Rev       Date:  2015-05-17       Impact factor: 9.754

Review 3.  Microscopic polyangiitis.

Authors:  Sharon A Chung; Philip Seo
Journal:  Rheum Dis Clin North Am       Date:  2010-06-11       Impact factor: 2.670

4.  Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients.

Authors:  L Guillevin; B Durand-Gasselin; R Cevallos; M Gayraud; F Lhote; P Callard; J Amouroux; P Casassus; B Jarrousse
Journal:  Arthritis Rheum       Date:  1999-03

5.  Successful Immunosuppressive Treatment of Mixed Connective Tissue Disease Complicated by Microscopic Polyangiitis.

Authors:  Shuzo Sato; Makiko Yashiro; Naoki Matsuoka; Manabu Uematsu; Tomoyuki Asano; Hiroko Kobayashi; Hiroshi Watanabe; Hiromasa Ohira
Journal:  Tohoku J Exp Med       Date:  2016-06       Impact factor: 1.848

Review 6.  Microscopic polyangiitis: Clinical presentation.

Authors:  Peter M Villiger; Loïc Guillevin
Journal:  Autoimmun Rev       Date:  2010-07-23       Impact factor: 9.754

Review 7.  Dermatomyositis: Diagnosis and treatment.

Authors:  Reid Waldman; Madeline E DeWane; Jun Lu
Journal:  J Am Acad Dermatol       Date:  2019-07-04       Impact factor: 11.527

8.  Clinical features and outcomes of microscopic polyangiitis in Korea.

Authors:  Ji Seon Oh; Chang-Keun Lee; Yong Gil Kim; Seong-Su Nah; Hee-Bom Moon; Bin Yoo
Journal:  J Korean Med Sci       Date:  2009-04-20       Impact factor: 2.153

9.  Muscle weakness as a presenting symptom in ANCA-associated vasculitis.

Authors:  Hiroshi Oiwa; Takashi Kurashige
Journal:  Eur J Rheumatol       Date:  2017-11-02

10.  EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.

Authors:  M Yates; R A Watts; I M Bajema; M C Cid; B Crestani; T Hauser; B Hellmich; J U Holle; M Laudien; M A Little; R A Luqmani; A Mahr; P A Merkel; J Mills; J Mooney; M Segelmark; V Tesar; K Westman; A Vaglio; N Yalçındağ; D R Jayne; C Mukhtyar
Journal:  Ann Rheum Dis       Date:  2016-06-23       Impact factor: 27.973

View more
  2 in total

1.  Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma.

Authors:  Vincenza Granata; Roberta Fusco; Andrea Belli; Valentina Borzillo; Pierpaolo Palumbo; Federico Bruno; Roberta Grassi; Alessandro Ottaiano; Guglielmo Nasti; Vincenzo Pilone; Antonella Petrillo; Francesco Izzo
Journal:  Infect Agent Cancer       Date:  2022-03-28       Impact factor: 2.965

Review 2.  A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls.

Authors:  Federica De Muzio; Francesca Grassi; Federica Dell'Aversana; Roberta Fusco; Ginevra Danti; Federica Flammia; Giuditta Chiti; Tommaso Valeri; Andrea Agostini; Pierpaolo Palumbo; Federico Bruno; Carmen Cutolo; Roberta Grassi; Igino Simonetti; Andrea Giovagnoni; Vittorio Miele; Antonio Barile; Vincenza Granata
Journal:  Diagnostics (Basel)       Date:  2022-07-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.